Eosinophile Granulomatose und Polyangiitis – Diagnostik und Therapie | SpringerLink
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
ANCA specificities in patients with AAV. | Download Table
Vaskulitiden und eosinophile Lungenerkrankungen | SpringerLink
Vasculitis of a muscle arteriole with fibrinoid necrosis... | Download Scientific Diagram
DE112016001013T5 - ANTIBODIES, USES AND METHODS - Google Patents
DE112016001013T5 - ANTIBODIES, USES AND METHODS - Google Patents
Baseline characteristics at diagnosis and induction treatment of 174... | Download Table
DE112016001013T5 - ANTIBODIES, USES AND METHODS - Google Patents
DE112016001013T5 - ANTIBODIES, USES AND METHODS - Google Patents
a) Median GFR during follow-up in diagnostic groups GPA and MPA. For... | Download Scientific Diagram
S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden | SpringerLink
DE112015001085T5 - Antibodies, uses and procedures - Google Patents
DE112015001085T5 - Antibodies, uses and procedures - Google Patents
Wegener-Granulomatose und mikroskopische Polyangiitis | SpringerLink
Vaskulitiden und eosinophile Lungenerkrankungen | SpringerLink
irheuma
Wegener-Granulomatose und mikroskopische Polyangiitis | SpringerLink
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
Pulmonale granulomatöse Erkrankungen und pulmonale Manifestationen systemischer Granulomatosen | SpringerLink
